# Grander Acquisition LLC – FDA Inspection, Jul 13, 2018

Source: https://www.keypedia.com/records/fda_inspections/grander-acquisition-llc/2386eca8-71eb-44ea-ac72-c127c7c719e4
Source feed: FDA_Inspections

> FDA inspection 1058841 of Grander Acquisition LLC, July 13, 2018. Classification: Voluntary Action Indicated (VAI). 8 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1058841
- Company Name: Grander Acquisition LLC
- Inspection Date: 2018-07-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 8

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kelly-d-moore/a5778f12-e968-4fc9-8391-b2cb5753232a)
- [FDA Associated Person](https://www.keypedia.com/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da)
- [FDA Associated Person](https://www.keypedia.com/people/travis-s-bradley/4d7756cb-65fd-4bd6-be24-25710668e6d8)

Company: https://www.keypedia.com/companies/grander-acquisition-llc/5284c15a-e78f-450d-b0a1-db384037f1b0

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d